Home › Funds › Clayton, Dubilier & Rice, LLC › AGL

Clayton, Dubilier & Rice, LLC position in AGL

AGILON HEALTH INC · Health Care

Clayton, Dubilier & Rice, LLC reported holding 4,000,000 shares of AGL (AGILON HEALTH INC) in its Q3 2026 13F filing — a position valued at US$318.4M, representing 43.91% of its reported portfolio and ranking #1 among its reported holdings. Clayton, Dubilier & Rice, LLC has disclosed AGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.00M sh
Reported value held$318.36M
Portfolio Weight43.91%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Clayton, Dubilier & Rice, LLC's AGL position evolved

Clayton, Dubilier & Rice, LLC first disclosed a stake in AGL in Q3 2023 at 100,000,000 shares (US$1.78B). Across 13 filings, Clayton, Dubilier & Rice, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 4,000,000 shares valued at US$318.4M. Notable position changes include a 96% trim in Q1 2026 (shares rose 1255% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 100.00M $1.78B New
Q4 2023 100.00M $1.25B Hold
Q1 2024 100.00M $610.00M Hold
Q2 2024 100.00M $654.00M Hold
Q3 2024 100.00M $393.00M Hold
Q4 2024 100.00M $190.00M Hold
Q1 2025 100.00M $433.00M Hold
Q2 2025 100.00M $230.00M Hold
Q3 2025 100.00M $103.00M Hold
Q4 2025 100.00M $69.00M Hold
Q1 2026 4.00M $31.64M Reduce
Q2 2026 4.00M $428.72M Hold
Q3 2026 4.00M $318.36M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AGL and 13F data

AGL (AGILON HEALTH INC) is a Health Care company. 33 other funds we track also report a position in AGL — the largest reported positions include North Peak Capital Management, LLC (US$126.1M), Durable Capital Partners LP (US$47.2M), Rock Springs Capital Management LP (US$28.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AGL

All AGL fund holders →

FAQ

How long has Clayton, Dubilier & Rice, LLC held AGL?

Clayton, Dubilier & Rice, LLC has disclosed AGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Clayton, Dubilier & Rice, LLC's current position in AGL?

As of Q3 2026, Clayton, Dubilier & Rice, LLC holds 4.00M shares of AGL (AGILON HEALTH INC), valued at $318.36M, representing 43.91% of its reported portfolio and ranking #1.

Has Clayton, Dubilier & Rice, LLC been buying or selling AGL?

In the latest 13F filing (Q3 2026), Clayton, Dubilier & Rice, LLC held unchanged its position in AGL.

Which other funds hold AGL?

Other major institutional holders of AGL include North Peak Capital Management, LLC, Durable Capital Partners LP, Rock Springs Capital Management LP, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.